Kevin Pollack Insider Trading $OPNT OPIANT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kevin Pollack.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin Pollack. Kevin Pollack is Director in PRESSURE BIOSCIENCES INC ($PBIO) and in MAGNEGAS CORP ($MNGA) and Director in MAGNEGAS CORP ($MNGA) and Chief Financial Officer in OPIANT PHARMACEUTICALS, INC. ($MDRV) and See Remarks in OPIANT PHARMACEUTICALS, INC. ($OPNT) and Director in Taronis Fuels, Inc. ($TRNF).
Kevin Pollack in OPIANT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kevin Pollack: See Remarks, Chief Financial Officer
Holdings: 4,820 shares
Current Value: $37,644
Latest Transaction: Jan 17 2017
$OPNT Market Capitalization: $15.43M
$OPNT Previous Close: $7.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Kevin Pollack in OPIANT PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TRNX, OPNT, PBIO, TRNF
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17 2017 | OPNT | OPIANT PHARMACEUTI ... | Pollack Kevin | See Remarks | Buy | P | 6.98 | 4,820 | 33,644 | 4,820 | 0 to 4.8 K |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 7.25 | 500,000 | 3,625,000 | 1,580,000 | |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 8.00 | 200,000 | 1,600,000 | 1,080,000 | |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 5.00 | 150,000 | 750,000 | 880,000 | |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 6.00 | 75,000 | 450,000 | 730,000 | |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 20.00 | 50,000 | 1,000,000 | 655,000 | |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 15.00 | 50,000 | 750,000 | 605,000 | |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 10.00 | 165,000 | 1,650,000 | 555,000 | |
| Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 8.00 | 190,000 | 1,520,000 | 390,000 |
Page: 1